Previous 10 | Next 10 |
2023-10-06 10:35:53 ET More on Health Care Sector SPDR September Labor Report Preview: Full Employment To Infinity Stagflation Playbook: Short Tech (QQQ/ARKK) And Long Healthcare (XLV) Citi turns cautious on pharmaceuticals and biotech BofA Securities: ...
- 18 VenoValve patients enrolled over the final two months of the study - Surge in VenoValve demand exceeded the enrollment limit - Topline safety and efficacy readout and PMA eligibility now expected to occur in Q4 2023, Q2 2024, and Q3 2024, respectively IRVINE, CA / ACCESSWIRE / ...
- enVVe development cycle to be reduced by 6 months - Application for enVVe pivotal trial now expected to be ready by end of 2024 IRVINE, CA / ACCESSWIRE / October 6, 2023 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care f...
Up to an additional $34 million of capital may become available from milestone-driven warrants in Q2, 2024 upon the release of initial topline efficacy data from the VenoValve pivotal trial Up to an additional $41 million of capital may become available from milestone-driven warrants upon ex...
- Ended the quarter with $29.8 million in cash and investments with quarterly burn of $4.4 million - in line with Company guidance - Cash on hand sufficient to fund its current operations past the release of topline safety and efficacy data from the SAVVE® study and through the end of 20...
2023-07-19 13:19:29 ET Gainers: SMX Public Limited Company ( SMX ) +37% . Marti Technologies ( MRT ) +31% . Carvana ( CVNA ) +29% . 60 Degrees Pharmaceuticals ( SXTP ) +27% . Wheels Up Experience ( UP ) +26% . enVVeno Medical...
2023-07-14 08:15:40 ET First Wave BioPharma ( FWBI ) -32% . Healthcare Triangle ( HCTI ) -31% . SunCar Technology Group ( SDA ) -30% . Rockwell Medical ( RMTI ) -30% . Cadrenal Therapeutics ( CVKD ) -30% . Viasat ( VSAT ) -...
IRVINE, CA / ACCESSWIRE / July 14, 2023 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today reminded investors that it will host a virtual KOL event on Tuesday, July 18, 2023, at 3:00 PM ET. ...
57 patients enrolled to date in the SAVVE® study Full SAVVE enrollment expected by year-end July 13 - Company to participate in investor event to further discuss enrollment July 18 - KOL event with two SAVVE study Principal Investigators IRVINE, CA / ACCESSWIRE / July 5, ...
- Ended the quarter with $34.2 million in cash and investments with quarterly burn of $4.9 million - in line with Company projections - Cash expected to support operations through the end of 2024, including release of SAVVE topline data and TAVVE first-in-human study data IRVINE, CA / AC...
News, Short Squeeze, Breakout and More Instantly...
enVVeno Medical Corp Com Company Name:
NVNO Stock Symbol:
NASDAQ Market:
enVVeno Medical Corp Com Website:
Live video webcast with Robert Berman, Chief Executive Officer of enVVeno Medical on Thursday, June 27 th at 4:00 PM ET IRVINE, CA / ACCESSWIRE / June 25, 2024 / enVVeno Medical Corporation (NASDAQ:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatmen...
91% of Venous Ulcer Patients Evaluated at One Year Have Either Fully Healed Ulcers or Ulcers That Have Improved 100% of Venous Ulcers with a Duration of One Year or Less Prior to VenoValve Surgery Have Fully Healed 89% of Venous Ulcers with a Duration of More Than One Year Prior to Veno...
IRVINE, CA / ACCESSWIRE / June 17, 2024 / enVVeno Medical Corporation (Nasdaq:NVNO) ("enVVeno" or the "Company"), a company setting new standards of care for the treatment of venous disease, today announced that new interim venous ulcer healing data from the VenoValve U.S. pivotal trial will be ...